COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders, NICE guideline [NG167], NICE

On 31 March 2021, NICE integrated content from the NHS England specialty guide on rheumatology during the coronavirus pandemic into this guideline. This includes information on making treatment decisions based on the person ' s condition and their medicines, advice on shielding and self-isolation, and recommendations on organising services based on COVID-19 prevalence.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news